Financial Health Assessment: TONROSE LIMITED

1. Financial Health Score: C+

Explanation: Tonrose Limited shows signs of recovery from a near-fatal condition in 2019, but recent vital signs indicate the patient is experiencing a relapse. While the balance sheet remains solvent, the return to losses in 2024 and a significant increase in short-term liabilities raise concerns about the sustainability of the recovery. The company is functional but vulnerable to external shocks.

2. Key Vital Signs

Liquidity Metrics

Interpretation: The current ratio has deteriorated from a healthy 2.31 to a still-adequate 1.83. However, the quick ratio is more concerning—dropping from 1.39 to 1.10, meaning the company has only just enough liquid assets (excluding stock) to cover immediate obligations. Like a patient with adequate blood pressure but narrowing margins, this leaves little room for error.

Leverage & Solvency

Interpretation: The debt-to-equity ratio has increased significantly from 0.78 to 1.18, meaning creditors now have a greater claim on assets than shareholders. This is akin to elevated cholesterol—the patient is functioning, but the underlying risk profile has worsened substantially.

Profitability Indicators

Interpretation: The £87,660 decline in retained profits indicates the company made a loss in 2024, reversing the profit trend from 2023. The reduction in employees from 15 to 12 suggests cost-cutting measures are underway—a common symptom when a business is trying to stabilise its condition.

3. Diagnosis

Overall Financial Condition: Stable but Weakening

The Patient's History: Tonrose Limited has been through a significant financial trauma. In 2019, the company had negative net assets of (£47,344)—effectively insolvent on a net asset basis, with total liabilities exceeding total assets. This was a critical condition requiring major intervention.

Between 2019 and 2022, the company underwent what appears to be substantial restructuring. Total assets contracted dramatically from £5.2M to £1.4M, suggesting significant asset disposals or write-downs. The company emerged from this restructuring smaller but with positive net assets.

Current Symptoms:

1. Rising Current Liabilities (Chronic Condition): Current liabilities surged by 39.6% from £654,934 to £914,275. This is the most concerning symptom. Specifically: - Trade creditors increased by 45% (£248,209 → £360,487)—suggesting the company is stretching supplier payment terms - Other creditors nearly doubled (£219,460 → £432,882), with £406,732 secured on company assets - This pattern is like a patient increasingly relying on credit to maintain daily functions

2. Return to Losses (Acute Flare-up): The £87,660 loss in 2024 follows a £32,005 profit in 2022, indicating the recovery was fragile and potentially temporary.

3. Increasing Group Intercompany Debt (Circulatory Dependency): Amounts owed by group undertakings increased from £124,482 to £217,357, suggesting the company is increasingly intertwined with its parent, The 1897 Group Limited. This could indicate either support or dependency.

4. Operating Lease Surge (Future Obligation): Lease commitments jumped from £11,504 to £115,595, suggesting the company has taken on significant new property or equipment commitments. This represents a substantial future cash outflow requirement.

5. Cash Improvement (Misleading Vital Sign): While cash improved from £24,669 to £73,958, this appears to be driven more by increased borrowing and creditor stretching rather than operational cash generation. The patient appears more hydrated, but the fluid is coming from questionable sources.

6. Stock Increase: Stocks rose from £602,737 to £663,217 (10% increase), which could indicate either anticipated demand or slow-moving inventory.

Positive Signs: - Net assets remain positive at £780,865 - Cash position has improved - The company has maintained banking facilities - Trade debtors decreased (£676,897 → £532,776), suggesting improved collection or lower sales - The parent company appears supportive

4. Recommendations

Immediate Actions (Critical Care)

1. Liability Management: The 39.6% increase in current liabilities requires urgent attention. Negotiate extended payment terms with key suppliers where possible, and develop a structured plan to reduce creditor balances. This is the financial equivalent of managing a fever before it becomes dangerous.

2. Cash Flow Forecasting: With only £73,958 in cash against £914,275 in current liabilities, the company needs robust 13-week cash flow forecasting. The £10,023 overdraft (secured on all assets) provides minimal buffer.

3. Review Secured Debt: £406,732 of other creditors are secured on company assets. Understand the terms of these facilities—any breach of covenants could trigger accelerated repayment demands.

Medium-Term Actions (Rehabilitation)

4. Profitability Recovery: The return to losses must be reversed. Conduct a thorough review of margin erosion—examine whether the textile wholesale market is experiencing structural pressure and whether pricing or cost adjustments are needed.

5. Stock Management: With £663,217 in stock (40% of current assets), ensure inventory is turning efficiently. Slow-moving stock in wholesale textiles can quickly become impaired.

6. Intercompany Relationship: Clarify the nature of the £217,357 owed by group undertakings. Is this genuine trading or financial support? If the latter, understand the parent's commitment level and whether this funding could be withdrawn.

7. Lease Commitments: The dramatic increase in operating lease commitments (£11,504 → £115,595) needs scrutiny. Ensure the company can service these obligations from operational cash flow.

Long-Term Actions (Preventative Care)

8. Strategic Review: As a 60-year-old business in the textile wholesale sector, Tonrose needs to assess its long-term market position. The 2019-2020 restructuring suggests the business model was fundamentally challenged.

9. Working Capital Efficiency: Target a current ratio above 2.0 and a quick ratio above 1.5 through a combination of improved profitability, debtor management, and controlled creditor growth.

10. Deleveraging Plan: Develop a clear path to reduce the debt-to-equity ratio back below 1.0, ideally targeting the 0.78 level seen in 2023.

Risk Factors to Monitor